These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 13392574)
1. [Micromethod in determination of antimony in blood and urine in visceral leishmaniasis during solusurmin therapy]. LAPIN LN Vopr Med Khim; 1956; 2(4):309-15. PubMed ID: 13392574 [No Abstract] [Full Text] [Related]
2. [Treatment of infantile visceral leishmaniasis with solusurmin according to material of the parasitological department of the Tashkent City Sanitary-Epidemiological Station]. MIKHAILOV VG; STARTSEVA MA Med Parazitol (Mosk); 1961; 30():563-7. PubMed ID: 14473694 [No Abstract] [Full Text] [Related]
3. [METABOLISM OF ANTIMONY IN CHILDREN WITH VISCERAL LEISHMANIASIS TREATED WITH SOLUSURMIN. II]. FUZAILOV IuM Med Parazitol (Mosk); 1964; 33():438-43. PubMed ID: 14250146 [No Abstract] [Full Text] [Related]
4. [The level of antimony in dogs with visceral leishmaniasis treated with solusurmin]. FUZAILOV IuM Med Parazitol (Mosk); 1962; 31():723-7. PubMed ID: 13945955 [No Abstract] [Full Text] [Related]
5. [Antimony resistance in the treatment of visceral leishmaniasis]. MIRZOIAN NA Med Parazitol (Mosk); 1957; 26(3):277-80. PubMed ID: 13482777 [No Abstract] [Full Text] [Related]
6. [Treatment of visceral leishmaniasis with solusurmin in children]. KARAKHODZHAEV BKh Pediatriia; 1953; 4():60-1. PubMed ID: 13088230 [No Abstract] [Full Text] [Related]
7. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives]. WILDE H; DI CARLO FC; PESSAT OA Rev Med Cordoba; 1956 Sep; 44():319-31. PubMed ID: 13420979 [No Abstract] [Full Text] [Related]
8. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives: personal observation]. DI CARLO FC; PESSAT OA; WILDE H Dia Med; 1956 Nov; 28(84):2629-31; passim. PubMed ID: 13397380 [No Abstract] [Full Text] [Related]
9. [Toxic nephritis during the course of antimony treatment of kala-azar]. BOUDIN G; PEPIN B; MORIN Concours Med; 1957 Jun; 79(24):2927-9. PubMed ID: 13447377 [No Abstract] [Full Text] [Related]
10. Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony. Harms G; Zwingenberger K; Sandkamp B; Omena S; Pedrosa C; Richter J; Rosenkaimer F; Feldmeier H; Bienzle U J Interferon Res; 1993 Feb; 13(1):39-41. PubMed ID: 8454909 [TBL] [Abstract][Full Text] [Related]
11. The use of recombinant gamma interferon associated with pentavalent antimony in therapy for visceral leishmaniasis. Badaro R Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():376-7. PubMed ID: 3151000 [No Abstract] [Full Text] [Related]
12. [Azotemic nephritis during antimony therapy of a case of infantile visceral leishmaniasis]. CHARLAS R; BENABADJI A Maroc Med; 1962 Dec; 41():1180-2. PubMed ID: 14020224 [No Abstract] [Full Text] [Related]
13. [The role of the sweat glands in excreting antimony from the body in people living in the biogeochemical provinces of the Fergana Valley]. Fuzaĭlov IuM Gig Tr Prof Zabol; 1992; (5):13-5. PubMed ID: 1427342 [TBL] [Abstract][Full Text] [Related]
15. [Secretion of antimony and stilbamidine in the treatment of visceral leishmaniasis in children]. MIKHAILOV VG Farmakol Toksikol; 1959; 22(2):175-8. PubMed ID: 13653152 [No Abstract] [Full Text] [Related]